切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - PKB - 5-HT7 Receptors - Sphingosine kinases (SphKs) - Microtubule/Tubulin

10 件产品

每页
清除全部
  1. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  2. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  3. K145
    B1298 K145
    Target: Sphingosine kinases (SphKs)
    Summary: SphK2抑制剂
      Soluble in DMSO
  4. Cabazitaxel
    B2157 Cabazitaxel
     3 Citation
    中文名: 卡巴他赛
    Target: Microtubule/Tubulin
    Summary: 微管相关抑制剂
      ≥22.3 mg/mL
      insoluble in H2O
  5. SKI II
    B2226 SKI II
    Target: Sphingosine kinases (SphKs)
    Summary: 鞘氨醇激酶(SK)抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  6. Vincristine sulfate
    A1765 Vincristine sulfate
    中文名: 硫酸长春新碱
    Target: Microtubule/Tubulin
    Summary: 微管的破坏者,抗肿瘤剂
      ≥46.15 mg/mL
      ≥58.5 mg/mL
  7. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP激酶抑制剂
      ≥18.872 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. PF-543
    A3717 PF-543
     1 Citation
    Target: Sphingosine kinases (SphKs)
    Summary: SphK1选择性抑制剂
      ≥23.3 mg/mL
      insoluble in H2O
  10. Epothilone D
    A3394 Epothilone D
    中文名: 埃博霉素 D
    Target: Microtubule/Tubulin
    Summary: 天然聚酮化合物
      Soluble in DMSO

10 件产品

每页